ObjectivesWe hypothesized that three-dimensional pseudocontinuous arterial spin labelling (pCASL) may have similar efficacy in astrocytic tumour grading as dynamic susceptibility contrast-enhanced perfusion-weighted imaging (DSC-PWI), and the grading accuracy may be further improved when combined with apparent diffusion coefficient (ADC) values.MethodsForty-three patients with astrocytic tumours were studied using diffusion weighted imaging (DWI), pCASL, and DSC-PWI. Histograms of ADC and normalized tumour cerebral blood flow values (nCBF on pCASL and nrCBF on DSC-PWI) were measured and analyzed.ResultsThe mean 10 % ADC value was the DWI parameter that provided the best differentiation between low-grade astrocytoma (LGA) and high-grade astrocytoma (HGA). The nCBF and nrCBF (1.810 ± 0.979 and 2.070 ± 1.048) in LGA were significantly lower than those (4.505 ± 2.270 and 5.922 ± 2.630) in HGA. For differentiation between LGA and HGA, the cutoff values of 0.764 × 10-3 mm2/s for mean 10 % ADC, 2.374 for nCBF, and 3.464 for nrCBF provided the optimal accuracy (74.4 %, 86.1 %, and 88.6 %, respectively). Combining the ADC values with nCBF or nrCBF could further improve the grading accuracy to 97.7 % or 95.3 %, respectively.ConclusionspCASL is an alternative to DSC-PWI for astrocytic tumour grading. The combination of DWI and contrast-free pCASL offers a valuable choice in patients with risk factors.Key Points• pCASL shows positive correlation with DSC-PWI in astrocytic tumour grading.• ADC values based on ADC histograms can be an objective method.• Combination of DWI and pCASL or DSC-PWI can improve grading accuracy.

The present study aimed to investigate the association between the content and distribution of fat in the pancreas and liver in patients with type 2 diabetes mellitus (T2DM). A total of 70 patients newly diagnosed with T2DM (T2DM group) and 30 healthy volunteers (normal control group) were enrolled in the present study. Dual-echo magnetic resonance (MR) chemical shift imaging was used to measure the fat content of the liver and the head, body and tail regions of the pancreas. In addition, the distribution of fat in the various regions of the pancreas, as well as the average fat content of the pancreas versus the liver, were compared. The fat content of the pancreatic head, body and tail regions of the T2DM group were 5.59±4.70, 4.80±3.75 and 4.89±3.86%, respectively. The fat content of these regions in the normal control group were 3.89±2.47, 3.30±2.11 and 3.23±2.23%, respectively. The average fat content of the pancreas was 5.19±3.75% for the T2DM group and 3.47±2.00% for the normal control group. The average fat content of the liver was 9.87±3.19% for the T2DM group and 7.24±2.38% for the normal control group. Therefore, the results from MR chemical shift imaging suggested that there were no significant differences in the distribution of fat between the pancreas of patients newly diagnosed with T2DM and that from the healthy population; however, the average fat content in the pancreas of the T2DM group was significantly higher (F=3.597; P<0.05), as compared with the normal control group. In addition, there was no correlation between the fat contents in the pancreas and liver in patients newly diagnosed with T2DM and the healthy population.

Cerebral blood flow (CBF) in the human primary visual cortex is correlated with the loss of visual function in neuro-ophthalmological diseases. Advanced three-dimensional pseudo-continuous arterial spin labeling (3D pCASL), as a non-invasive method to access the CBF, can be a novel measurement to detect the visual cortex. The objective of the study was to assess the intra- and inter-scanner reliability of 3D pCASL of the visual cortex in healthy adults and suggest the selection of different post-labeling delay times (PLDs). For this reason, 3D pCASL was conducted in two 3.0T MR three times with twelve healthy volunteers at an interval of 10–15 days. The 1st and 3rd tests were performed on scanner-1, and the 2nd test was performed on scanner-2. The value of the CBF was abstracted from the visual cortex with two PLDs. The intra- and inter-scanner reliability and reproducibility were evaluated with the intraclass correlation coefficient (ICC) and Bland-Altman plots. By estimating the mean value of the CBF in the visual cortex, the intra-scanner results demonstrated the higher reliability (ICC for PLD = 1.5 second presented at 0.743 compared with 0.829 for PLD = 2.5 seconds), and the Bland-Altman plots showed the reproducibility at a longer PLD. We conclude that the calibrated 3D pCASL approach provides a highly reproducible measurement of the CBF of the visual cortex that can serve as a useful quantitative probe for research conducted at multiple centers and for the long-term observation of the clinical effects of neuro-opthalmological diseases.

The 3D FDP-FSPGR can be used for high-spatial-resolution demonstration and large coverage of the BA wall and the ostia of the adjacent branch arteries. This sequence will make it possible to evaluate therapeutic effects in clinical studies.

Objective: To evaluate the diagnostic value of magnetic resonance diffusion-weighted imaging (DWI) and three-dimensional arterial spin labelling perfusion imaging (3D-ASL) in distinguishing cavernous haemangioma from parasellar meningioma, using histological data as a reference standard. Methods: Patients with parasellar meningioma or parasellar cavernous haemangioma underwent conventional T 1 -and T 2 -weighted magnetic resonance imaging (MRI) followed by DWI and 3D-ASL using a 3.0 Tesla MRI. The minimum apparent diffusion coefficient (minADC) from DWI and the maximal normalized cerebral blood flow (nCBF) from 3D-ASL were measured in each tumour. Diagnosis was confirmed by histology. Results: MinADC was significantly lower and nCBF significantly higher in meningioma (n ¼ 19) than cavernous haemangioma (n ¼ 15). There was a significant negative correlation between minADC and nCBF (r ¼ À0.605). Conclusion: DWI and 3D-ASL are useful in differentiating cavernous haemangiomas from parasellar meningiomas, particularly in situations when the appearance on conventional MRI sequences is otherwise ambiguous.